Sionna Therapeutics, Inc. Common Stock Dividends

The next dividend date for Sionna Therapeutics, Inc. Common Stock has not yet been scheduled.

What is a Dividend Date

When we talk about a dividend date, we’re referring specifically to the ex-dividend date.

This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.

The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.

Most brokerages will automatically credit the dividend to your account once it’s issued.

Historical Dividends for Sionna Therapeutics, Inc. Common Stock (SION)

No Results.
DateDeclaration DateRecord DatePayment DateAmount
No Results.

More About Sionna Therapeutics, Inc. Common Stock

Country
USA
Full Time Employees
41

Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; and SION-719 and SION-451, which are nucleotide-binding domain 1 stabilizers in Phase 1 trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.

Owning Sionna Therapeutics, Inc. Common Stock Stock on the Dividend Date

If you own Sionna Therapeutics, Inc. Common Stock stock on the ex-dividend date, then you earn the associated dividend.

Theoretically, the price of Sionna Therapeutics, Inc. Common Stock stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Sionna Therapeutics, Inc. Common Stock stock).

Therefore, it is typically not expected that there is any incremental profit to be gained from buying Sionna Therapeutics, Inc. Common Stock stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Sionna Therapeutics, Inc. Common Stock dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.

Learning More Sionna Therapeutics, Inc. Common Stock Dividends

You can contact us any time if you would like to ask questions about Sionna Therapeutics, Inc. Common Stock dividends or anything else related to the stock market.